OSAA Innovation, an award-winning Danish medtech company specializing in advanced and connected infusion therapy solutions, today announced it will showcase its next-generation IV ecosystem at WHX Dubai 2026 (Feb 10–13, Booth S17.C110), as a part of the Danish Pavilion.

The global home infusion therapy market is experiencing a massive growth, projected to reach USD 92.23 billion by 2032. This trend is mirrored in the Middle East, where the home healthcare market is heading toward a projected USD 9.84 billion by 2030. Recent data underscores this acceleration: nearly 70% of UAE residents have utilized home-based medical services at least once, citing convenience and infection control as key motivations.

OSAA Innovation is positioned at the forefront of the global  "Hospital-at-Home" shift. The company’s presence at WHX Dubai highlights a strategic commitment to bridging the gap between hospital-grade precision and transition of the delivery of the infusion treatments to the alternative care settings, through the lens of connected care and remote treatment monitoring.

Redefining the Infusion Landscape

As the Middle East healthcare sector is undergoing a massive transformation, driven by, introduction of digital healthcare management systems, remote treatment monitoring and high AI adoption, the MENA digital health market is projected to surge to nearly USD 30 billion by 2028. 

This shift toward intelligent, digitally enabled care is supporting the trend and accelerating the demand for a new class of medical devices that are both mobile and fully connected. The scale of this opportunity is immense; with the global connected medical device market now reaching an estimated 2.2 to 3.3 million units, providers are moving swiftly to digitize the patient experience and transition hospital-grade precision into the home.

“WHX Dubai is the perfect platform to demonstrate how OSAA Innovation is redefining IV therapy through cutting-edge, connected solutions,” said Ahmed Hessam, CEO and Founder of OSAA Innovation. “With the GCC’s aging population and the UAE’s National Strategy for Wellbeing 2031, home healthcare has shifted from a supplementary service to a critical piece of strategic infrastructure. Transitioning to domiciliary IV therapy is the next logical step and we are excited to connect with regional partners to accelerate safer, smarter infusion therapy for patients and healthcare professionals.”

Key Solutions at OSAA Innovation’s booth:

Visitors to the OSAA Innovation stand will experience a complete IV product ecosystem designed for the modern "Connected Health" era:

• iV-View®: A centralized remote-monitoring system allowing hospital staff to track infusion statuses across multiple wards from a single station.
• iV4Vita®: An advanced volumetric infusion pump designed specifically to enhance safety and efficiency within alternative care and "Hospital-at-Home" settings.
• iV2Vita®: A wireless connected monitor that tracks drop counts with 99% accuracy, providing unprecedented real-time data.
• iV-Warmer®: A specialized heater for blood and fluid transfusion, ensuring patient comfort and clinical safety.

Alongside the connectivity-first IV solutions the company will also demonstrate its breakthrough mobility-focused infusion pumps.

Healthcare professionals, industry leaders, and stakeholders are encouraged to visit OSAA Innovation’s Booth to learn more about the company’s latest innovations, explore collaborative opportunities to advance  infusion therapy, as well discuss strategic distributor partnerships across the MENA region.

A Global Track Record of Excellence

OSAA Innovation arrives in Dubai with a legacy of international acclaim, having secured prestigious honors including the Red Dot Design Award (2022), Australian Good Design Award (2024), and the German Design Award (2025). This foundation of healthcare design excellence ensures that OSAA Innovation’s products are not only technically superior but also patient-centered and intuitive for clinicians.